Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay

Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay

This protocol describes an ELISA-based procedure for accurate measurement of SARS-CoV-2 spike protein-receptor binding domain (RBD) neutralization efficacy by murine immune serum. The procedure requires a small amount of S-protein/RBD and angiotensin converting enzyme-2 (ACE2). A high-throughput, si...

Full description

Bibliographic Details
Main Authors:	Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Daniel Watterson, Paul R. Young, Istvan Toth, Mariusz Skwarczynski
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Vaccines
Subjects:	SARS-CoV-2 receptor binding domain spike protein binding inhibition assay neutralization assay competitive ELISA
Online Access:	https://www.mdpi.com/2076-393X/9/12/1493

Similar Items

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
by: Ahmed O. Shalash, et al.
Published: (2022-04-01)

High concordance of ELISA and neutralization assays allows for the detection of antibodies to individual AAV serotypes
by: Matthew R. Gardner, et al.
Published: (2022-03-01)

Application and Validation of SARS-CoV-2 RBD Neutralizing ELISA Assay
by: Z. S Mousa, et al.
Published: (2022-02-01)

Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
by: Ahmed O. Shalash, et al.
Published: (2021-08-01)

Performance Evaluation of Three Antibody Binding Assays, a Neutralizing Antibody Assay, and an Interferon-Gamma Release Assay for SARS-CoV-2 According to Vaccine Type in Vaccinated Group
by: Minjeong Nam, et al.
Published: (2023-12-01)

A competitive ligand-binding assay for the detection of neutralizing antibodies against dostarlimab (TSR-042)
by: Xiaolong Tom Zhang, et al.
Published: (2021-11-01)

Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection
by: Lili Wang, et al.
Published: (2023-10-01)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
by: Poonsook Keelapang, et al.
Published: (2023-08-01)

The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1)
by: Ahmad TAVAKOLI, et al.
Published: (2017-11-01)

Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
by: Philipp Girl, et al.
Published: (2022-02-01)

Modified ELISA for antibody avidity evaluation: The need for standardization
by: Victor Araujo Correa, et al.
Published: (2021-08-01)

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain
by: Xingsu Gao, et al.
Published: (2022-11-01)

Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
by: Thomas L. Rudge, et al.
Published: (2022-07-01)

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
by: Filipe Colaco Mariz, et al.
Published: (2023-11-01)

Quantifying Neutralizing Antibodies in Patients with COVID-19 by a Two-Variable Generalized Additive Model
by: Kuan-Ting Liu, et al.
Published: (2022-02-01)

RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers
by: Ruth Aguilar, et al.
Published: (2023-02-01)

Expression Profile and Ligand Screening of a Putative Odorant-Binding Protein, AcerOBP6, from the Asian Honeybee
by: Huiting Zhao, et al.
Published: (2021-10-01)

Evaluation of six serological ELISA kits available in Italy as screening tests for equine infectious anaemia surveillance
by: Roberto Nardini, et al.
Published: (2017-04-01)

Sensitivity of three thyrotropin receptor antibody assays in thyroid-associated orbitopathy
by: Sarić-Matutinović Marija, et al.
Published: (2022-01-01)

Development of a New Enzyme-Linked Immunosorbent Assay (ELISA) for Measuring the Content of PACAP in Mammalian Tissue and Plasma
by: Elisabeth Anne Adanma Obara, et al.
Published: (2023-10-01)

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
by: Heidi Syre, et al.
Published: (2022-10-01)

Phage vs. Phage: Direct Selections of Sandwich Binding Pairs
by: Emily C. Sanders, et al.
Published: (2023-03-01)

The instantly blocking-based fluorescent immunochromatographic assay for the detection of SARS-CoV-2 neutralizing antibody
by: Yizhe Li, et al.
Published: (2023-09-01)

Bioassay Development for Bispecific Antibodies—Challenges and Opportunities
by: Ames C. Register, et al.
Published: (2021-05-01)

Functional Analysis of Odorant-Binding Proteins 12 and 17 from Wheat Blossom Midge <i>Sitodiplosis mosellana</i> Géhin (Diptera: Cecidomyiidae)
by: Weining Cheng, et al.
Published: (2020-12-01)

1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
by: Amer H. Tarawneh, et al.
Published: (2022-01-01)

A Cross-Sectional Study of SARS-CoV-2 Seroprevalence between Fall 2020 and February 2021 in Allegheny County, Western Pennsylvania, USA
by: Lingqing Xu, et al.
Published: (2021-06-01)

COVID-19 serum can be cross-reactive and neutralizing against the dengue virus, as observed by the dengue virus neutralization test
by: Himadri Nath, et al.
Published: (2022-09-01)

Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
by: Ying Huang, et al.
Published: (2023-09-01)

Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis
by: Harriet N. Garlant, et al.
Published: (2022-05-01)

Estandarización y validación de un ELISA para la cuantificación de antitoxina tetánica en suero humano
by: Cira Virgen Rodríguez Pelier, et al.

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
by: Katharine H. D. Crawford, et al.
Published: (2020-05-01)

Peptide Specific Nanoplastic Detection Based on Sandwich Typed Localized Surface Plasmon Resonance
by: Seungju Oh, et al.
Published: (2021-10-01)

A GBP 130 derived peptide from Plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro
by: Jorge E Suarez, et al.
Published: (2000-08-01)

Comparison of a Micro-Neutralization Test with the Rapid Fluorescent Focus Inhibition Test for Measuring Rabies Virus Neutralizing Antibodies
by: Todd G. Smith, et al.
Published: (2017-07-01)

Novel Neutralizing Epitope of PEDV S1 Protein Identified by IgM Monoclonal Antibody
by: Techit Thavorasak, et al.
Published: (2022-01-01)

Serodiagnosis of Przhevalskiana spp. Infestation in Goats Using a Competitive ELISA
by: A. Bagheri, et al.
Published: (2020-06-01)

In Vitro Tests for Assessing the Neutralizing Ability of Snake Antivenoms: Toward the 3Rs Principles
by: José María Gutiérrez, et al.
Published: (2021-01-01)

Development of a rapid neutralization testing system for Rhinovirus C15 based on the enzyme-linked immunospot assay
by: Zhenhong Zhou, et al.
Published: (2022-09-01)

The Occluded Epitope Residing in Spike Receptor-Binding Motif Is Essential for Cross-Neutralization of SARS-CoV-2 Delta Variant
by: Weeraya Thongkum, et al.
Published: (2022-06-01)